Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-29

FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for phentermine and topiramate by Teva Pharmaceuticals for weight-management use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine and topiramate (Phentermine and topiramate)

Snippet

SUPPL AP for PHENTERMINE AND TOPIRAMATE (PHENTERMINE AND TOPIRAMATE)